CANCER IMMUNOLOGY IMMUNOTHERAPY

Journal Title
CANCER IMMUNOLOGY IMMUNOTHERAPY

CANCER IMMUNOL IMMUN

ISSN / eISSN
0340-7004 / 1432-0851
Aims and Scope
Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers. This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions.

The journal publishes short editorials including "position papers," general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology.
Subject Area

IMMUNOLOGY

ONCOLOGY

CiteScore
11.30 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Oncology Q1 #41/366
Medicine - Cancer Research Q1 #34/214
Medicine - Immunology and Allergy Q1 #34/211
Medicine - Immunology Q1 #37/217
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
IMMUNOLOGY - SCIE Q2
ONCOLOGY - SCIE Q1
H-index
104
Country/Area of Publication
UNITED STATES
Publisher
Springer Berlin Heidelberg
Publication Frequency
Monthly
Year Publication Started
1976
Annual Article Volume
219
Open Access
NO
Contact
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
The speed is exceptionally slow.
2021-03-01

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started